Literature DB >> 17631896

Crystallographic and mass spectrometric characterisation of eIF4E with N7-alkylated cap derivatives.

Christopher J Brown1, Iain McNae, Peter M Fischer, Malcolm D Walkinshaw.   

Abstract

Structural complexes of the eukaryotic translation initiation factor 4E (eIF4E) with a series of N(7)-alkylated guanosine derivative mRNA cap analogue structures have been characterised. Mass spectrometry was used to determine apparent gas-phase equilibrium dissociation constants (K(d)) values of 0.15 microM, 13.6 microM, and 55.7 microM for eIF4E with 7-methyl-GTP (m(7)GTP), GTP, and GMP, respectively. For tight and specific binding to the eIF4E mononucleotide binding site, there seems to be a clear requirement for guanosine derivatives to possess both the delocalised positive charge of the N(7)-methylated guanine system and at least one phosphate group. We show that the N(7)-benzylated monophosphates 7-benzyl-GMP (Bn(7)GMP) and 7-(p-fluorobenzyl)-GMP (FBn(7)GMP) bind eIF4E substantially more tightly than non-N(7)-alkylated guanosine derivatives (K(d) values of 7.0 microM and 2.0 microM, respectively). The eIF4E complex crystal structures with Bn(7)GMP and FBn(7)GMP show that additional favourable contacts of the benzyl groups with eIF4E contribute binding energy that compensates for loss of the beta and gamma-phosphates. The N(7)-benzyl groups pack into a hydrophobic pocket behind the two tryptophan side-chains that are involved in the cation-pi stacking interaction between the cap and the eIF4E mononucleotide binding site. This pocket is formed by an induced fit in which one of the tryptophan residues involved in cap binding flips through 180 degrees relative to structures with N(7)-methylated cap derivatives. This and other observations made here will be useful in the design of new families of eIF4E inhibitors, which may have potential therapeutic applications in cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17631896     DOI: 10.1016/j.jmb.2007.06.033

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  31 in total

1.  Dynamical insight into Caenorhabditis elegans eIF4E recognition specificity for mono-and trimethylated structures of mRNA 5' cap.

Authors:  Katarzyna Ruszczyńska-Bartnik; Maciej Maciejczyk; Ryszard Stolarski
Journal:  J Mol Model       Date:  2010-06-10       Impact factor: 1.810

Review 2.  PROTACs: great opportunities for academia and industry.

Authors:  Xiuyun Sun; Hongying Gao; Yiqing Yang; Ming He; Yue Wu; Yugang Song; Yan Tong; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2019-12-24

3.  Crystal structure of a minimal eIF4E-Cup complex reveals a general mechanism of eIF4E regulation in translational repression.

Authors:  Kerstin Kinkelin; Katharina Veith; Marlene Grünwald; Fulvia Bono
Journal:  RNA       Date:  2012-07-25       Impact factor: 4.942

4.  Characterization of the Raptor/4E-BP1 interaction by chemical cross-linking coupled with mass spectrometry analysis.

Authors:  Kimberly Coffman; Bing Yang; Jie Lu; Ashley L Tetlow; Emelia Pelliccio; Shan Lu; Da-Chuan Guo; Chun Tang; Meng-Qiu Dong; Fuyuhiko Tamanoi
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

5.  Synthesis of 7-benzylguanosine cap-analogue conjugates for eIF4E targeted degradation.

Authors:  Tanpreet Kaur; Arya Menon; Amanda L Garner
Journal:  Eur J Med Chem       Date:  2019-01-31       Impact factor: 6.514

Review 6.  Therapeutic Opportunities in Eukaryotic Translation.

Authors:  Jennifer Chu; Jerry Pelletier
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

7.  Conformational changes induced in the eukaryotic translation initiation factor eIF4E by a clinically relevant inhibitor, ribavirin triphosphate.

Authors:  Laurent Volpon; Michael J Osborne; Hiba Zahreddine; Andrea A Romeo; Katherine L B Borden
Journal:  Biochem Biophys Res Commun       Date:  2013-04-10       Impact factor: 3.575

8.  Nontoxic chemical interdiction of the epithelial-to-mesenchymal transition by targeting cap-dependent translation.

Authors:  Brahma Ghosh; Alexey O Benyumov; Phalguni Ghosh; Yan Jia; Svetlana Avdulov; Peter S Dahlberg; Mark Peterson; Karen Smith; Vitaly A Polunovsky; Peter B Bitterman; Carston R Wagner
Journal:  ACS Chem Biol       Date:  2009-05-15       Impact factor: 5.100

9.  Structural insights into parasite eIF4E binding specificity for m7G and m2,2,7G mRNA caps.

Authors:  Weizhi Liu; Rui Zhao; Craig McFarland; Jeffrey Kieft; Anna Niedzwiecka; Marzena Jankowska-Anyszka; Janusz Stepinski; Edward Darzynkiewicz; David N M Jones; Richard E Davis
Journal:  J Biol Chem       Date:  2009-08-26       Impact factor: 5.157

10.  Treatment of breast and lung cancer cells with a N-7 benzyl guanosine monophosphate tryptamine phosphoramidate pronucleotide (4Ei-1) results in chemosensitization to gemcitabine and induced eIF4E proteasomal degradation.

Authors:  Shui Li; Yan Jia; Blake Jacobson; Joel McCauley; Robert Kratzke; Peter B Bitterman; Carston R Wagner
Journal:  Mol Pharm       Date:  2013-02-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.